NATIONAL HEALTHCARE CORP - FORM 10-Q

Attached files

file	filename
EXCEL - IDEA: XBRL DOCUMENT - NATIONAL HEALTHCARE CORP	Financial_Report.xls
EX-32 - NATIONAL HEALTHCARE CORP	exhibit32nhc.htm
EX-31 - NATIONAL HEALTHCARE CORP	exhibit311adams.htm
EX-31 - NATIONAL HEALTHCARE CORP	exhibit312daniel.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2011
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to ____________

Commission file number 001–13489

(Exact name of registrant as specified in its Charter)

Delaware		52–2057472
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization		Identification No.)

100 E. Vine Street
Murfreesboro, TN 37130
(Address of principal executive offices)
(Zip Code)

(615) 890–2020
Registrant's telephone number, including area code

Indicate by check mark whether the registrant: (1) Has filed all reports required to be filed by Section 13 or 15(d), of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such period that the registrant was required to submit and post such files). Yes [x] No [ ] Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated file," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated filer [ ]	Accelerated filer [x]

Non-accelerated filer (Do not check if a smaller reporting company) [ ]	Smaller reporting company [ ]

Indicate by check mark whether the registrant is a shell company (as is defined in Rule 12b–2 of the Exchange
Act). Yes [ ] No [x]

13,831,995 shares of common stock of the registrant were outstanding as of November 2, 2011

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Statements of Income

(Unaudited)

(in thousands, except share and per share amounts)


				Three Months Ended September 30				Nine Months Ended September 30
				2011		2010		2011		2010
REVENUES:
	Net patient revenues		$	182,134	$	165,344	$	536,531	$	486,153
	Other revenues			14,930		13,207		44,264		42,644
		Net operating revenues		197,064		178,551		580,795		528,797

COSTS AND EXPENSES:
	Salaries, wages and benefits			106,870		98,531		320,425		292,287
	Other operating			54,807		49,296		148,084		146,657
	Facility rent			10,000		9,518		29,744		28,440
	Depreciation and amortization			7,307		6,800		21,344		19,890
	Interest			136		136		333		396
		Total costs and expenses		179,120		164,281		519,930		487,670

Income Before Non-Operating Income				17,944		14,270		60,865		41,127
Non-Operating Income				5,140		5,424		14,856		14,958

Income Before Income Taxes				23,084		19,694		75,721		56,085
Income Tax Provision				(5,873)		(4,611)		(26,175)		(18,745)
Net Income				17,211		15,083		49,546		37,340

Dividends to preferred stockholders				(2,167)		(2,169)		(6,503)		(6,505)

Net income available to common stockholders			$	15,044	$	12,914	$	43,043	$	30,835

Earnings Per Common Share:
	Basic		$	1.09	$	.95	$	3.13	$	2.25
	Diluted		$	1.05	$	.95	$	3.02	$	2.25

Weighted Average Common Shares Outstanding:
	Basic			13,807,995		13,649,174		13,762,084		13,705,477
	Diluted			16,444,749		13,650,916		16,404,305		13,707,590

The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.

NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Balance Sheets

(in thousands)


				September 30, 2011		December 31, 2010
				(unaudited)
Assets
	Current Assets:
		Cash and cash equivalents		$	53,158	$	28,478
		Restricted cash and cash equivalents			49,118		51,992
		Marketable securities			80,089		85,116
		Restricted marketable securities			84,686		70,877
		Accounts receivable, less allowance for doubtful accounts of $4,020 and $3,942, respectively			66,875		76,559
		Inventories			7,242		7,853
		Prepaid expenses and other assets			2,201		1,251
			Total current assets		343,369		322,126

	Property and Equipment:
		Property and equipment, at cost			654,498		640,150
		Accumulated depreciation and amortization			(222,478)		(203,758)
			Net property and equipment		432,020		436,392

	Other Assets:
		Deposits			412		302
		Goodwill			20,320		20,320
		Notes receivable			22,098		23,671
		Deferred income taxes			10,933		12,000
		Investments in limited liability companies			17,175		14,204
			Total other assets		70,938		70,497
			Total assets	$	846,327	$	829,015

The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.

The interim condensed consolidated balance sheet at December 31, 2010 is taken from the audited consolidated financial statements at that date.

NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)


					September 30, 2011		December 31, 2010
					(unaudited)
Liabilities and Stockholders’ Equity

	Current Liabilities:
		Trade accounts payable		$	9,449	$	10,947
		Accrued payroll			49,395		52,055
		Amounts due to third party payors			18,337		17,667
		Accrued risk reserves			96,322		105,059
		Deferred income taxes			12,200		14,186
		Other current liabilities			14,313		17,895
		Dividends payable			6,351		5,997
			Total current liabilities		206,367		223,806

	Long-Term Debt				10,000		10,000
	Other Noncurrent Liabilities				16,954		18,861
	Deferred Lease Credits				303		1,212
	Deferred Revenue				13,707		13,990

	Commitments, Contingencies and Guarantees

	Stockholders’ Equity:
		Series A Convertible Preferred Stock; $.01 par value; 25,000,000 shares authorized; 10,838,526 and 10,840,608 shares, respectively, issued and outstanding; stated at liquidation of $15.75 per share			170,515		170,548
		Common stock, $.01 par value; 30,000,000 shares authorized; 13,831,995 and 13,637,258 shares, respectively, issued and outstanding			138		136
		Capital in excess of par value			137,457		128,061
		Retained earnings			256,992		226,114
		Unrealized gains on marketable securities, net of taxes			33,894		36,287
			Total stockholders’ equity		598,996		561,146
			Total liabilities and stockholders’ equity	$	846,327	$	829,015

The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.

The interim condensed consolidated balance sheet at December 31, 2010 is taken from the audited consolidated financial statements at that date.

NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Statements of Cash Flows

(Unaudited)


						Nine Months Ended September 30
						2011		2010
Cash Flows From Operating Activities:						(in thousands)
	Net income				$	49,546	$	37,340
	Adjustments to reconcile net income to net cash
		provided by operating activities:
		Depreciation and amortization				21,344		19,890
		Provision for doubtful accounts receivable				1,689		1,059
		Equity in earnings of unconsolidated investments				(7,203)		(6,899)
		Distributions from unconsolidated investments				4,232		5,455
		Gains on sale of restricted marketable securities				(399)		(702)
		Deferred income taxes				680		913
		Stock-based compensation				2,253		205
		Changes in operating assets and liabilities:
			Restricted cash and cash equivalents			(8,027)		(4,098)
			Accounts receivable			7,995		(3,099)
			Income tax receivable			-		3,470
			Inventories			611		(307)
			Prepaid expenses and other assets			(950)		(457)
			Trade accounts payable			(1,498)		(830)
			Accrued payroll			(2,660)		(6,612)
			Amounts due to third party payors			670		1,941
			Other current liabilities and accrued risk reserves			(12,319)		(55)
			Entrance fee deposits			(1,343)		(519)
			Other noncurrent liabilities			(1,907)		(1,752)
			Deferred income			1,060		856
				Net cash provided by operating activities		53,774		45,799
Cash Flows From Investing Activities:
		Additions to and acquisitions of property and equipment				(17,881)		(18,919)
		Acquisition of homecare business				-		(14,342)
		Collections of notes receivable				1,573		1,026
		Change in restricted cash and cash equivalents				10,901		48,018
		Purchase of restricted marketable securities				(48,233)		(85,484)
		Sale of restricted marketable securities				35,858		36,017
				Net cash used in investing activities		(17,782)		(33,684)
Cash Flows From Financing Activities:
		Tax benefit from stock-based compensation				(40)		189
		Dividends paid to preferred stockholders				(6,503)		(6,505)
		Dividends paid to common stockholders				(11,810)		(10,982)
		Issuance of common shares				7,152		1,012
		Repurchase of common shares				-		(5,944)
		Change in deposits				(111)		(16)
		Other				-		(23)
				Net cash used in financing activities		(11,312)		(22,269)
Net Increase (Decrease) in Cash and Cash Equivalents						24,680		(10,154)
Cash and Cash Equivalents, Beginning of Period						28,478		39,022
Cash and Cash Equivalents, End of Period					$	53,158	$	28,868

The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.

NATIONAL HEALTHCARE CORPORATION

Interim Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share and per share amounts)

(unaudited)


		Preferred Stock			Common Stock				Capital in Excess of Par Value		Retained Earnings		Unrealized Gains on Marketable Securities		Total Stock-holders’ Equity
		Shares		Amount	Shares		Amount
Balance at December 31, 2009		10,841,062	$	170,555	13,717,701	$	137	$	130,867	$	197,140	$	27,080	$	525,779
	Net income	–		–	–		–		–		37,340		–		37,340
	Unrealized gains on securities (net of tax of $5,669)	–		–	–		–		–		–		9,149		9,149
	Total comprehensive income														46,489
	Stock-based compensation	–		–	30,000		–		205		–		–		205
	Tax benefit from exercise of stock options	–		–	–		–		189		–		–		189
	Shares sold - options exercised	–		–	30,864		1		1,011		–		–		1,012
	Shares repurchased				(182,900)		(2)		(5,942)						(5,944)
	Shares issued in conversion of preferred stock to common stock	(448)		(7)	107		–		7		–		–		–
	Dividends declared to preferred stockholders ($0.60 per share)	–		–	–		–		–		(6,505)		–		(6,505)
	Dividends declared to common stockholders ($0.82 per share)	–		–	–		–		–		(11,236)		–		(11,236)
Balance at September 30, 2010		10,840,614	$	170,548	13,595,772	$	136	$	126,337	$	216,739	$	36,229	$	549,989

Balance at December 31, 2010		10,840,608	$	170,548	13,637,258	$	136	$	128,061	$	226,114	$	36,287	$	561,146
	Net income	–		–	–		–		–		49,546		–		49,546
	Unrealized losses on securities (net of tax of $1,599)	–		–	–		–		–		–		(2,393)		(2,393)
	Total comprehensive income														47,153
	Stock-based compensation	–		–	–		–		2,253		–		–		2,253
	Tax expense from exercise of stock options	–		–	–		–		(40)		–		–		(40)
	Shares sold – options exercised	–		–	194,234		2		7,150		–		–		7,152
	Shares issued in conversion of preferred stock to common stock	(2,082)		(33)	503		–		33		–		–		–
	Dividends declared to preferred stockholders ($0.60 per share)	–		–	–		–		–		(6,503)		–		(6,503)
	Dividends declared to common stockholders ($0.88 per share)	–		–	–		–		–		(12,165)		–		(12,165)
Balance at September 30, 2011		10,838,526	$	170,515	13,831,995	$	138	$	137,457	$	256,992	$	33,894	$	598,996

The accompanying notes to interim condensed consolidated financial statements are an integral part of these consolidated statements.

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

Note 1 – Description of Business

National HealthCare Corporation (“NHC” or the “Company”) is a leading provider of long-term health care services. We operate or manage, through certain affiliates, 76 long-term health care centers with 9,548 beds in 10 states and provide other services in one additional state. These operations are provided by separately funded and maintained subsidiaries. We provide long-term health care services to patients in a variety of settings including long-term nursing centers, managed care specialty units, sub-acute care units, Alzheimer's care units, hospice programs, homecare programs, assisted living centers and independent living centers. In addition, we provide insurance services, management and accounting services, and lease properties to operators of long-term health care centers.

Note 2 – Summary of Significant Accounting Policies

The listing below is not intended to be a comprehensive list of all of our significant accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by generally accepted accounting principles, with limited need for management’s judgment in their application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. See our audited December 31, 2010 consolidated financial statements and notes thereto which contain accounting policies and other disclosures required by generally accepted accounting principles. Our audited December 31, 2010 consolidated financial statements are available at our web site: www.nhccare.com.

Basis of Presentation

The unaudited condensed consolidated financial statements to which these notes are attached include all normal, recurring adjustments which are necessary to fairly present the financial position, results of operations and cash flows of NHC. All significant intercompany transactions and balances have been eliminated in consolidation. We assume that users of these interim financial statements have read or have access to the audited December 31, 2010 consolidated financial statements and Management’s Discussion and Analysis of Financial Condition and Results of Operations and that the adequacy of additional disclosure needed for a fair presentation, except in regard to material contingencies, may be determined in that context. Accordingly, footnotes and other disclosures which would substantially duplicate the disclosure contained in our most recent annual report to stockholders have been omitted. This interim financial information is not necessarily indicative of the results that may be expected for a full year for a variety of reasons.

Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and cause our reported net income to vary significantly from period to period.

Revenue Recognition – Third Party Payors

Approximately 70% of our net patient revenues are derived from Medicare, Medicaid, and other government programs. Amounts earned under these programs are subject to review by the Medicare and Medicaid intermediaries or their agents. In our opinion, adequate provision has been made for any adjustments that may result from these reviews. Any differences between our original estimates of reimbursements and subsequent revisions are reflected in operations in the period in which the revisions are made often due to final determination or the period of payment no longer being subject to audit or review. We have made provisions of approximately $18,337,000 and $17,667,000 as of September 30, 2011 and December 31, 2010, respectively, for various Medicare and Medicaid current and prior year cost reports and claims reviews.

Revenue Recognition - Private Pay

For private pay patients in skilled nursing or assisted living facilities, we bill room and board in advance for the current month with payment being due upon receipt of the statement in the month the services are performed. Charges for ancillary, pharmacy, therapy and other services to private patients are billed in the month following the performance of services; however, all billings are recognized as revenue when the services are performed.

Revenue Recognition - Subordination of Fees and Uncertain Collections

We provide management services to certain long-term care facilities and to others we provide accounting and financial services. We generally charge 6% to 7% of net revenues for our management services and a predetermined fixed rate per bed for the accounting and financial services. Our policy is to recognize revenues associated with both management services and accounting and financial services on an accrual basis as the services are provided. However, under the terms of our management contracts, payments for our management services are subject to subordination to other expenditures of the long-term care center being managed. Furthermore, for certain of the third parties with whom we have contracted to provide services and which we have determined, based on insufficient historical collections and the lack of expected future collections, that collection is not reasonably assured, our policy is to recognize income only in the period in which the amounts are realized. We may receive payment for the unpaid and unrecognized management fees in whole or in part in the future only if cash flows from the operating and investing activities of the centers or proceeds from the sale of the centers are sufficient to pay the fees. There can be no assurance that such future cash flows will occur. The realization of such previously unrecognized revenue could cause our reported net income to vary significantly from period to period.

We agree to subordinate our fees to the other expenses of a managed center because we believe we know how to improve the quality of patient services and finances of a long-term care center and because subordinating our fees demonstrates to the owner and employees of the managed center how confident we are of the impact we can have in making the center operations successful. We may continue to provide services to certain managed centers despite not being fully paid currently so that we may be able to collect unpaid fees in the future from improved operating results and because the incremental savings from discontinuing services to a center may be small compared to the potential benefit. Also, we may benefit from providing other ancillary services to the managed center.

Accrued Risk Reserves

We are principally self-insured for risks related to employee health insurance, workers’ compensation and professional and general liability claims. Our accrued risk reserves primarily represent the accrual for self-insured risks associated with employee health insurance, workers’ compensation and professional and general liability claims. The accrued risk reserves include a liability for reported claims and estimates for incurred but unreported claims. Our policy with respect to a significant portion of our workers’ compensation and professional and general liability claims is to use an actuary to estimate our exposure for claims obligations (for both asserted and unasserted claims). Our health insurance reserve is based on our known claims incurred and an estimate of incurred but unreported claims determined by our analysis of historical claims paid. We reassess our accrued risk reserves on a quarterly basis.

Professional liability remains an area of particular concern to us. The entire long term care industry has seen a dramatic increase in personal injury/wrongful death claims based on alleged negligence by nursing homes and their employees in providing care to residents. As of September 30, 2011, we and/or our managed centers are defendants in 28 such claims inclusive of years 2002 through 2011. It remains possible that those pending matters plus potential unasserted claims could exceed our reserves, which could have a material adverse effect on our financial position, results of operations and cash flows. It is also possible that future events could cause us to make significant adjustments or revisions to these reserve estimates and cause our reported net income to vary significantly from period to period.

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

We maintain insurance coverage for incidents occurring in all providers owned or leased by us. The coverages include both primary policies and excess policies. In all years, settlements, if any, in excess of available insurance policy limits and our own reserves would be expensed by us.

Credit Losses

Certain of our accounts receivable from private paying patients and certain of our notes receivable are subject to credit losses. We have attempted to reserve for expected accounts receivable credit losses based on our past experience with similar accounts receivable and believe our reserves to be adequate.

We monitor and evaluate the carrying amount of our notes receivable in accordance with ASC Topic 310, Receivables. It is possible, however, that the accuracy of our estimation process could be materially impacted as the composition of the receivables changes over time. We continually review and refine our estimation process to make it as reactive to these changes as possible. However, we cannot guarantee that we will be able to accurately estimate credit losses on these balances. It is possible that future events could cause us to make significant adjustments or revisions to these estimates and cause our reported net income to vary significantly from period to period.

Uncertain Tax Positions

We continually evaluate for uncertain tax positions. These uncertain positions may arise where tax laws may allow for alternative interpretations or where the timing of recognition of income is subject to judgment. We believe we have adequate provisions for our uncertain tax positions including related penalties and interest. However, because of uncertainty of interpretation by various tax authorities and the possibility that there are issues that have not been recognized by management, we cannot guarantee we have accurately estimated our tax liabilities.

New Accounting Pronouncements

In September 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2011-08, which is included in the Codification under ASC 350, “Intangibles – Goodwill and Other.” The revised standard is intended to reduce the cost and complexity of the annual goodwill impairment test by providing entities an option to perform a “qualitative” assessment to determine whether further impairment testing is necessary. This standard is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011, with early adoption permitted. We believe this adoption will not have a material impact on the Company’s consolidated financial statements.

In July 2011, the FASB issued ASU No. 2011-07, which is included in the Codification under ASC 954, “Health Care Entities.” This updated guidance requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires certain qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions. This update is effective for fiscal years beginning after December 15, 2011, and will be adopted by the Company in the first quarter of 2012. We believe this adoption will not have a material impact on the Company’s consolidated financial statements.

In June 2011, the FASB issued ASU No. 2011-05, which is included in the Codification under ASC 220, “Comprehensive Income.” This updated guidance requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. This standard is required to be applied retrospectively and is effective for fiscal years beginning after December 15, 2011, and will be adopted by the Company in the first quarter of 2012. The Company has not yet determined which method it will elect upon adoption.

In May 2011, the FASB issued ASU No. 2011-04, which is included in the Codification under ASC 820, “Fair Value Measurement.” The amendments in this update result in common fair value measurement and disclosure requirements in U.S. GAAP and International Financial Reporting Standards (IFRS). The amendments

are effective for fiscal years beginning after December 15, 2011, and will be adopted by the Company in the first quarter of 2012. We believe this adoption will not have a material impact on the Company’s consolidated financial statements.

In April 2011, the FASB issued ASU No. 2011-02, which is included in the Codification under ASC 470, “Debt.” This updated guidance clarifies when a loan modification or restructuring is considered a troubled debt restructuring (TDR). This guidance became effective for the first interim or annual period beginning on or after June 15, 2011, which was adopted by the Company on July 1, 2011. The adoption of this guidance did not have a material impact on our consolidated financial statements.

In December 2010, the FASB issued ASU No. 2010-29, which is included in the Codification under ASC 805, “Business Combinations.” This update provides guidance on the disclosure of supplemental pro forma information for business combinations. This guidance became effective for our interim and annual reporting periods beginning January 1, 2011. The adoption of this guidance did not have a material impact on our condensed consolidated financial statements.

Also in December 2010, the FASB issued ASU No. 2010-28, which is included in the Codification under ASC 350, “Intangibles – Goodwill and Other.” This update provides guidance on applying the goodwill impairment test for reporting units with zero or negative carrying amounts. This guidance became effective for our interim and annual reporting periods beginning January 1, 2011. The adoption of this guidance did not have a material impact on our condensed consolidated financial statements.

In August 2010, the FASB issued ASU No. 2010-24, which is included in the Codification under ASC 954, “Health Care Entities.” This update provides clarification to companies in the healthcare industry on the accounting for professional liability and workers’ compensation insurance. This update states that receivables related to insurance recoveries should not be netted against the related claim liability and such claim liabilities should be determined without considering insurance recoveries. This guidance became effective for our interim and annual reporting periods beginning January 1, 2011. The adoption of this guidance did not have a material impact on our condensed consolidated financial statements.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the Company’s financial position or results of operations.

Note 3 – Other Revenues

Other revenues are outlined in the table below. Revenues from insurance services include premiums for workers’ compensation, health insurance, and professional liability insurance policies that our wholly-owned limited purpose insurance subsidiaries have written for certain long-term health care centers to which we provide management or accounting services. Revenues from management and accounting services include management and accounting fees provided to managed and other long-term health care centers. Revenues from rental income include health care real estate properties owned by us and leased to third party operators. "Other" revenues include miscellaneous health care related earnings.

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

Other revenues include the following:


		Three Months Ended September 30				Nine Months Ended September 30
(in thousands)		2011		2010		2011		2010
Insurance services	$	3,950	$	4,164	$	12,046	$	12,914
Management and accounting services fees		5,894		4,306		16,465		15,288
Rental income		4,756		4,436		14,368		13,207
Other		330		301		1,385		1,235
	$	14,930	$	13,207	$	44,264	$	42,644

Management Fees from National

Certain of our affiliates manage five long-term care centers owned by National Health Corporation ("National"). During the nine months ended September 30, 2011 and 2010, we recognized management fees and interest on management fees of $2,676,000 and $3,142,000, respectively, from these centers.

The unpaid fees from the five centers owned by National, because the amount collectable could not be reasonably determined when the management services were provided, and because we cannot estimate the timing or amount of expected future collections, will be recognized as revenues only when fixed or determinable and collectibility of these fees can be reasonably assured. Under the terms of our management agreement with National, the payment of these fees to us may be subordinated to other expenditures of the five long-term care centers. We continue to manage these centers so that we may be able to collect our fees in the future and because the incremental savings from discontinuing services to a center may be small compared to the potential benefit. We may receive payment for the unrecognized management fees in whole or in part in the future only if cash flows from the operating and investing activities of the five centers or the proceeds from the sale of the centers are sufficient to pay the fees. There can be no assurance that such future improved cash flows will occur.

Management Fees from Other Nursing Centers

We continue to manage eight long-term care centers (excluding the five National centers) for third-party owners where the management fees are recognized only when realized. During the nine months ended September 30, 2011 and 2010, we recognized $2,271,000 and $1,043,000, respectively, of management fees and interest from these eight long-term care centers.

The unpaid fees from these eight centers, because of insufficient historical collections and the lack of expected future collections are recognized only when realized. Under the terms of the management agreements, the payment of these fees to us may be subordinated to other expenditures of each of the long-term care centers. Our affiliates continue to manage these centers so that we may be able to collect our fees in the future and because the incremental savings from discontinuing services to a center may be small compared to the potential benefit. We may receive payment for the unrecognized management fees in whole or in part in the future only if cash flows from operating and investing activities of the centers or the proceeds from the sale of the centers are sufficient to pay the fees. There can be no assurance that such future improved cash flows will occur.

Rental Income

The health care properties currently owned and leased to third party operators include nine skilled nursing facilities and four assisted living communities. Effective January 1, 2011, we renewed the rental agreements with the third party operators. The rental agreements continue for a five year period ending on December 31, 2015.

Note 4 - Non-Operating Income

Non-operating income is outlined in the table below. Non-operating income includes equity in earnings of unconsolidated investments, dividends and other realized gains and losses on securities, and interest income. Our most significant equity method investment is a 57.4% non-controlling ownership interest in Caris HealthCare L.P., a business that specializes in hospice care services.


		Three Months Ended September 30				Nine Months Ended September 30
(in thousands)		2011		2010		2011		2010
Equity in earnings of unconsolidated investments	$	2,464	$	2,416	$	7,203	$	6,899
Dividends and other net realized gains and losses on sales of securities		1,410		1,597		3,928		4,060
Interest income		1,266		1,411		3,725		3,999
	$	5,140	$	5,424	$	14,856	$	14,958

Note 5 – Other Operating Expenses

Other operating expenses include the costs of care and services that we provide to the residents of our facilities and the costs of maintaining our facilities. Our primary patient care costs include drugs, medical supplies, purchased professional services, food, and professional liability insurance and licensing fees. The primary facility costs include utilities and property insurance.

Note 6 – Earnings per Share

Basic net income per share is computed based on the weighted average number of common shares outstanding for each period presented. Diluted net income per share reflects the potential dilution that would have occurred if securities to issue common stock were exercised, converted, or resulted in the issuance of common stock that would have then shared in our earnings.

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

The following table summarizes the earnings and the weighted average number of common shares used in the calculation of basic and diluted earnings per share.


		Three Months Ended September 30				Nine Months Ended September 30
(in thousands, except for share and per share amounts)		2011		2010		2011		2010
Basic:
Weighted average common shares outstanding		13,807,995		13,649,174		13,762,084		13,705,477
Net income	$	17,211	$	15,083	$	49,546	$	37,340
Dividends to preferred stockholders		(2,167)		(2,169)		(6,503)		(6,505)
Net income available to common stockholders	$	15,044	$	12,914	$	43,043	$	30,835
Earnings per common share, basic	$	1.09	$	.95	$	3.13	$	2.25

Diluted:
Weighted average common shares outstanding		13,807,995		13,649,174		13,762,084		13,705,477
Dilutive effect of stock options		8,366		-		12,431		1,210
Dilutive effect of restricted stock		5,031		1,742		6,303		903
Convertible preferred stock		2,623,357		-		2,623,487		-
Assumed average common shares outstanding		16,444,749		13,650,916		16,404,305		13,707,590

Net income available to common stockholders	$	15,044	$	12,914	$	43,043	$	30,835
Add dilutive preferred stock dividends for effect of assumed conversion of preferred stock		2,167		-		6,503		-

Net income for diluted earnings per common share	$	17,211	$	12,914	$	49,546	$	30,835
Earnings per common share, diluted	$	1.05	$	.95	$	3.02	$	2.25

In the above table, options to purchase 1,439,251 and 514,642 shares of our common stock have been excluded for 2011 and 2010, respectively, due to their anti-dilutive impact. We have excluded 2,623,862 of common shares issuable upon the conversion of preferred stock for both periods presented in 2010 due to their anti-dilutive impact.

Note 7 - Investments in Marketable Securities

Our investments in marketable securities are classified as available for sale securities. Realized gains and losses from securities sales are determined on the specific identification of the securities.

Marketable securities and restricted marketable securities consist of the following:


			September 30, 2011				December 31, 2010
(in thousands)			Amortized Cost		Fair Value		Amortized Cost		Fair Value
Investments available for sale:
	Marketable equity securities	$	29,604	$	80,089	$	29,604	$	85,116
Restricted investments available for sale:
	Corporate debt securities		34,437		35,137		28,683		29,182
	Commercial mortgage-backed securities		34,468		35,293		26,282		26,866
	U.S. Treasury securities		7,326		7,579		8,192		8,030
	U.S. government sponsored enterprise securities		-		-		2,340		2,423
	State and municipal securities		6,391		6,677		4,348		4,376
		$	112,226	$	164,775	$	99,449	$	155,993

Included in the available for sale marketable equity securities are the following:

(in thousands, except share amounts)


	September 30, 2011					December 31, 2010
	Shares		Cost		Fair Value	Shares		Cost		Fair Value
NHI Common Stock	1,630,642	$	24,734	$	68,699	1,630,642	$	24,734	$	73,412

The amortized cost and estimated fair value of debt securities classified as available for sale, by contractual maturity, are as follows:


		September 30, 2011				December 31, 2010
(in thousands)		Cost		Fair Value		Cost		Fair Value
Maturities:
Within 1 year	$	6,309	$	6,362	$	3,551	$	3,562
1 to 5 years		54,996		56,358		46,461		47,340
6 to 10 years		21,317		21,966		18,313		18,454
Over 10 years		-		-		1,520		1,521
	$	82,622	$	84,686	$	69,845	$	70,877

Gross unrealized gains related to available for sale securities are $52,870,000 and $56,911,000 as of September 30, 2011 and December 31, 2010, respectively. Gross unrealized losses related to available for sale securities were $321,000 and $367,000 as of September 30, 2011 and December 31, 2010, respectively.

Proceeds from the sale of investments in marketable securities during the nine months ended September 30, 2011 and 2010 were $35,858,000 and $36,017,000, respectively. Investment gains of $399,000 and $702,000 were realized on these sales during the nine months ended September 30, 2011 and 2010, respectively.

Note 8 - Fair Value Measurements

The carrying amounts of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The estimated fair value of notes receivable approximates the carrying value based principally on their underlying interest rates and terms, maturities, collateral and credit status of the receivables. Our long-term debt approximates fair value due to variable interest rates. At September 30, 2011 and December 31, 2010, there were no material differences between the carrying amounts and fair values of NHC’s financial instruments stated above.

The accounting standard for fair value measurements provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. Fair value is defined as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. This accounting standard establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs that may be used to measure fair value:

Level 1 – The valuation is based on quoted prices in active markets for identical instruments.

Level 2 – The valuation is based on observable inputs such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

Level 3 – The valuation is based on unobservable inputs that are supported by minimal or no market activity and that are significant to the fair value of the instrument. Level 3 valuations are typically performed using pricing models, discounted cash flow methodologies, or similar techniques that incorporate management’s own estimates of assumptions that market participants would use in pricing the instrument, or valuations that require significant management judgment or estimation.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement.

The Company determines fair value for marketable securities with Level 1 inputs through quoted market prices. The Company determines fair value for marketable securities with Level 2 inputs through broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency. Our Level 2 marketable securities have been initially valued at the transaction price and subsequently valued, at the end of each month, typically utilizing third party pricing services or other market observable data. The pricing services utilize industry standard valuation models, including both income and market based approaches and observable market inputs to determine value. These observable market inputs include reportable trades, benchmark yields, credit spreads, broker/dealer quotes, bids, offers, and other industry and economic events. We did not have any transfers of assets between Level 1 and Level 2 of the fair value measurement hierarchy during the nine months ended September 30, 2011.

The following table summarizes fair value measurements by level at September 30, 2011 and December 31, 2010 for assets and liabilities measured at fair value on a recurring basis (in thousands):


		Fair Value Measurements Using
September 30, 2011		Fair Value		Quoted Prices in Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	53,158	$	53,158	$	–	$	–
Restricted cash and cash equivalents		49,118		49,118		–		–
Marketable equity securities		80,089		80,089		–		–
Corporate debt securities		35,137		-		35,137		–
Commercial mortgage-backed securities		35,293		-		35,293		–
U.S. Treasury securities		7,579		7,579		-		–
State and municipal securities		6,677		-		6,677		–
Total financial assets	$	267,051	$	189,944	$	77,107	$	–


		Fair Value Measurements Using
December 31, 2010		Fair Value		Quoted Prices in Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	28,478	$	28,478	$	–	$	–
Restricted cash and cash equivalents		51,992		51,992		–		–
Marketable equity securities		85,116		85,116		–		–
Corporate debt securities		29,182		–		29,182		–
Commercial mortgage-backed securities		26,866		–		26,866		–
U.S. Treasury securities		8,030		8,030		–		–
U.S. government sponsored enterprise securities		2,423		–		2,423		–
State and municipal securities		4,376		–		4,376		–
Total financial assets	$	236,463	$	173,616	$	62,847	$	–

Note 9 - Long-Term Debt and Commitments

Long-term debt consists of the following:


	Weighted Average Interest Rate	Maturities		Long-Term Debt
(dollars in thousands)				9/30/11		12/31/10
Revolving Credit Facility, interest payable monthly	Variable, 1.24%	2011	$	–	$	–

Unsecured term note payable to National, interest payable quarterly, principal payable at maturity	Variable, 2.76%	2018		10,000		10,000
				10,000		10,000
Less current portion				–		–
			$	10,000	$	10,000

Note 10 - $75,000,000 Revolving Credit Facility

Effective October 26, 2011, we extended the maturity of our Credit Agreement (the "Credit Agreement") with Bank of America, N.A., as lender (the "Lender"). The Credit Agreement provides for a $75,000,000 revolving credit facility (the "Credit Facility"), of which up to $5,000,000 may be utilized for letters of credit.

Borrowings bear interest at either, (i) the Eurodollar rate plus 0.70% or (ii) the prime rate. Letter of credit fees are equal to 0.70% times the maximum amount available to be drawn under outstanding letters of credit.

Commitment fees are payable on the daily unused portion of the Credit Facility at a rate of fifteen (15) basis points per annum. NHC is permitted to prepay the loans outstanding under the Credit Facility at any time, without penalty.

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

The Credit Facility matures on October 25, 2012. We currently anticipate renewing the credit agreement at that time and while we have had no indication from the lender that there is any question about renewal, there has been no commitment at this time. If the Lender elects to consent to such extension, subject to certain conditions, the maturity date will be extended to the date which is 364 days after the then maturity date.

NHC’s obligations under the Credit Agreement are guaranteed by certain NHC subsidiaries and are secured by pledges by NHC and the guarantors of (i) 100% of the equity interests of domestic subsidiaries and (ii) up to 65% of the voting equity interests and 100% of the non-voting equity interests of foreign subsidiaries, in each case, held by NHC or the guarantors.

The Credit Agreement contains customary representations and warranties, and covenants, including covenants that restrict, among other things, asset dispositions, mergers and acquisitions, dividends, restricted payments, debt, liens, investments and affiliate transactions. The Credit Agreement contains customary events of default.

The Credit Facility is available for general corporate purposes, including working capital and acquisitions.

Note 11 – Stock-Based Compensation

NHC recognizes stock-based compensation for all stock options and restricted stock granted over the requisite service period using the fair value for these grants as estimated at the date of grant either using the Black-Scholes pricing model for stock options or the quoted market price for restricted stock.

The 2005 and 2010 Stock-Based Compensation Plans

The Compensation Committee of the Board of Directors (“the Committee”) has the authority to select the participants to be granted options; to designate whether the option granted is an incentive stock option (“ISO”), a non–qualified option, or a stock appreciation right; to establish the number of shares of common stock that may be issued upon exercise of the option; to establish the vesting provision for any award; and to establish the term any award may be outstanding. The exercise price of any ISO’s granted will not be less than 100% of the fair market value of the shares of common stock on the date granted and the term of an ISO may not be any more than ten years. The exercise price of any non–qualified options granted will not be less than 100% of the fair market value of the shares of common stock on the date granted unless so determined by the Committee.

In May 2005, our stockholders approved the 2005 Stock Option, Employee Stock Purchase, Physician Stock Purchase and Stock Appreciation Rights Plan (“the 2005 Plan”) pursuant to which 1,200,000 shares of our common stock were available to grant as stock-based payments to key employees, directors, and non-employee consultants. In March 2011, the Company granted stock options to purchase 756,583 shares of our common stock in accordance with the 2005 Plan. These particular stock options become vested and exercisable thirty days prior to the expiration date of the options, which is five years after the date of grant. At September 30, 2011, 30,000 shares were available for future grants under the 2005 Plan.

In May 2010, our stockholders approved the 2010 Omnibus Equity Incentive Plan (“the 2010 Plan”) pursuant to which 1,200,000 shares of our common stock were available to grant as stock-based payments to key employees, directors, and non-employee consultants. In March 2011, the Company granted stock options to purchase 443,417 shares of common stock in accordance with the 2010 Plan. These particular stock options become vested and exercisable thirty days prior to the expiration date of the options, which is five years after the date of the grant. In May 2011, the Company granted non-employee directors stock options to purchase 45,000 shares of common stock in accordance with the 2010 Plan. These particular stock options became vested and exercisable immediately and have a maximum five year term. At September 30, 2011, 534,952 shares were available for future grants under the 2010 Plan.

Compensation expense is recognized only for the awards that ultimately vest. Stock-based compensation totaled $2,253,000 and $205,000 for the nine months ended September 30, 2011 and 2010, respectively. The expense for the 2011 period increased $771,000 due to the Company choosing to accelerate the vesting date of options to purchase 158,000 shares of stock that were granted in June 2010. The options had an original vesting date in June 2015. At September 30, 2011, we had $8,471,000 of unrecognized compensation cost related to unvested stock-based compensation awards, which consisted of $7,727,000 for stock options and $744,000 for restricted stock. This expense will be recognized over the remaining weighted average vesting period, which is approximately 4.4 years for stock options and 2.1 years for restricted stock. Stock-based compensation is included in “Salaries, wages and benefits” in the Interim Condensed Consolidated Statements of Income.

Stock Options

The following table summarizes the assumptions used to value the options granted for the nine months ended September 30, 2011 and for the year ended December 31, 2010.


	2011	2010
Risk-free interest rate	2.02%	1.88%
Expected volatility	23.66%	25.30%
Expected life, in years	4.9 years	4.5 years
Expected dividend yield	3.62%	3.55%
Expected forfeiture rate	0.00%	0.00%

The following table summarizes our outstanding stock options for the nine months ended September 30, 2011 and for the year ended December 31, 2010.


	Number of Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value
Options outstanding at December 31, 2009	385,305	$	44.78
Options granted	180,485		35.55
Options exercised	(72,149)		36.69
Options cancelled or expired	(21,314)		32.01
Options outstanding at December 31, 2010	472,327		43.07
Options granted	1,263,715		46.65
Options exercised	(194,234)		36.82
Options cancelled or expired	(30,000)		44.25
Options outstanding at September 30, 2011	1,511,808	$	46.84	$	-

Options exercisable at September 30, 2011	293,177	$	47.50	$	-


Options Outstanding September 30, 2011	Exercise Prices	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life in Years
72,557	$37.70	$37.70	2.6
1,263,631	$45.80 - $46.69	$46.65	4.4
175,620	$51.50 - $52.50	$51.99	1.1
1,511,808		$46.84	3.9

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

Restricted Stock

The following table summarizes our restricted stock activity for the nine months ended September 30, 2011 and for the year ended December 31, 2010.


	Number of Shares		Weighted Average Grant Date Fair Value		Aggregate Intrinsic Value
Unvested restricted shares at December 31, 2009	–	$	–
Award shares granted	30,000		34.46
Award shares vested	–		–
Unvested restricted shares at December 31, 2010	30,000		34.46
Award shares granted	–		–
Award shares vested	6,000		34.46
Unvested restricted shares at September 30, 2011	24,000	$	34.46	$	–

The weighted average remaining contractual life of restricted stock at September 30, 2011 is 2.1 years.

Note 12 – Accounting for Uncertainty in Income Taxes

NHC continually evaluates for uncertain tax positions. Uncertain tax positions may arise where tax laws may allow for alternative interpretations or where the timing of recognition of income is subject to judgment. We believe we have made adequate provision for unrecognized tax benefits related to uncertain tax positions. However, because of uncertainty of interpretation by various tax authorities and the possibility that there are issues that have not been recognized by management, we cannot guarantee we have accurately estimated our tax liabilities. We believe that our liabilities reflect the anticipated outcome of known uncertain tax positions in conformity with ASC Topic 740, Income Taxes. Our liabilities for unrecognized tax benefits are presented in the consolidated balance sheets within Other Noncurrent Liabilities.

At September 30, 2011, we had $13,855,000 of unrecognized tax benefits, composed of $9,398,000 of deferred tax assets and $4,457,000 of permanent differences. Accrued interest and penalties of $3,099,000 relate to unrecognized tax benefits at September 30, 2011. Unrecognized tax benefits of $4,457,000, net of federal benefit, at September 30, 2011, attributable to permanent differences, would favorably impact our effective tax rate if recognized. Accrued interest and penalties of $1,480,000 relate to these permanent differences at September 30, 2011. We do not expect to recognize significant increases or decreases in unrecognized tax benefits within twelve months beginning September 30, 2011, except for the effect of decreases related to the lapse of statute of limitations estimated at $2,310,000, composed of temporary differences of $-0-, and permanent tax differences of $2,310,000. Interest and penalties of $638,000 relate to these permanent difference changes within 12 months beginning September 30, 2011.

Interest and penalties expense related to U.S. federal and state income tax returns are included within income tax expense.

The Company is no longer subject to U.S. federal and state examinations by tax authorities for years before 2008 (with certain state exceptions). Currently, there are no U.S. federal or state returns under examination.

Our deferred tax assets have been evaluated for realization based on historical taxable income, tax planning strategies, the expected timing of reversals of existing temporary differences and future taxable income anticipated. Our deferred tax assets are more likely than not to be realized in full due to the existence of sufficient taxable income of the appropriate character under the tax law. As such, there is no need for a valuation allowance.

Note 13 – Guarantees and Contingencies

Accrued Risk Reserves

We are self insured for risks related to health insurance and have wholly-owned limited purpose insurance companies that insure risks related to workers’ compensation and general and professional liability insurance claims both for our owned or leased entities and certain of the entities to which we provide management or accounting services. The liability we have recognized for reported claims and estimates for incurred but unreported claims totals $96,322,000 and $105,059,000 at September 30, 2011 and December 31, 2010, respectively. This liability is classified as a current liability based on the uncertainty regarding the timing of potential payments. The liability is included in accrued risk reserves in the interim condensed consolidated balance sheets and is subject to adjustment for actual claims incurred. It is possible that these claims plus unasserted claims could exceed our insurance coverages and our reserves, which could have a material adverse effect on our financial position, results of operations and cash flows.

As a result of the terms of our insurance policies and our use of wholly-owned limited purpose insurance companies, we have retained significant insurance risk with respect to workers’ compensation and general and professional liability. We use independent actuaries to estimate our exposures for claims obligations (for both asserted and unasserted claims) related to deductibles and exposures in excess of coverage limits, and we maintain reserves for these obligations. Such estimates are based on many variables including historical and statistical information and other factors.

Workers’ Compensation

For workers’ compensation, we utilize a wholly-owned Tennessee domiciled property/casualty insurance company to write coverage for NHC affiliates and for third-party customers. Policies are written for a duration of twelve months and cover only risks related to workers’ compensation losses. All customers are companies which operate in the long-term care industry. Business is written on a direct basis. Direct business coverage is written for statutory limits and the insurance company’s losses in excess of $1,000,000 per claim are covered by reinsurance.

For these workers’ compensation insurance operations, the premium revenues reflected in the interim condensed consolidated financial statements within "Other Revenues" for the nine months ended September 30, 2011 and 2010, respectively, are $3,894,000 and $3,827,000. Associated losses and expenses are reflected in the interim condensed consolidated financial statements as "Salaries, wages and benefits."

General and Professional Liability Lawsuits and Insurance

The long term care industry has experienced significant increases in both the number of personal injury/wrongful death claims and in the severity of awards based upon alleged negligence by nursing facilities and their employees in providing care to residents. As of September 30, 2011, we and/or our managed centers are currently defendants in 28 such claims covering the years 2002 through September 30, 2011.

In 2002, we established and capitalized a wholly-owned licensed liability insurance company. Thus, since 2002, insurance coverage for incidents occurring at all NHC owned providers, and most providers managed by us is provided through this wholly-owned insurance company.

Our coverages for all years include primary policies and excess policies. In 2002, deductibles were eliminated and first dollar coverage was provided through the wholly-owned insurance company, while the excess coverage was provided by a third party insuror.

For 2003-2011, both primary professional liability insurance coverage and excess coverage is provided through our wholly-owned liability insurance company. The primary coverage is in the amount of $1 million per incident, $3 million per location with an annual primary policy aggregate limit of $19.0 million for 2011, $17.0 million for 2009 and 2010, $16.0 million for 2008, $14.0 million for 2006 and 2007, and $12.0 million for 2003-

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

2005. The excess coverage is $7.5 million annual excess in the aggregate applicable to years 2003-2007 and subsequently for $9.0 million annual excess in the aggregate for years 2008-2011.

For these professional liability insurance operations, the premium revenues reflected in the financials as "Other Revenues" for the nine months ended September 30, 2011 and 2010, respectively, are $3,287,000 and $3,331,000. Associated losses and expenses including those for self-insurance are included in the interim condensed consolidated financial statements as "Other operating costs and expenses".

Other Matters

On July 24, 2009, the Company received a civil investigative demand from the Tennessee Attorney General’s Office, requesting production of documents related to NHC’s business relationships with non-profit entities. The Company has responded to the demand and complied as required with the terms of the demand.

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations.

Overview

Summary of Goals and Areas of Focus

Earnings

To monitor our earnings, we have developed budgets and management reports to monitor labor, census, and the composition of revenues.

Medicare Reimbursement Rate Changes

In July 2011, the Centers for Medicare and Medicaid Services ("CMS") announced a final rule reducing Medicare skilled nursing facility PPS payments in fiscal year 2012 by $3.87 billion, or 11.1% lower than payments for fiscal year 2011. We estimate the resulting decrease in revenue from the fiscal year 2012 Medicare rate changes will be approximately $24,000,000 annually or $6,000,000 quarterly. We are examining cost saving measures that are available to us to help mitigate the effects of a portion of the revenue decrease, but we are committed to maintaining the quality of care to our patients.

Development and Growth

We are undertaking to expand our long-term care operations while protecting our existing operations and markets. The following table lists our recent construction and purchase activities.


Type of Operation	Description	Size	Location	Placed in Service
Skilled Nursing	New Facility	120 Beds	Bluffton, SC	January 2010
Assisted Living	New Facility	45 Units	Mauldin, SC	March 2010
Homecare	Acquisition	353 ADC	Columbia, Rock Hill, and Summerville, SC	May, 2010
Skilled Nursing	Acquisition	120 Beds	Macon, MO	December, 2010
Skilled Nursing	Acquisition	120 Beds	Osage Beach, MO	December, 2010
Skilled Nursing	Acquisition	120 Beds	Springfield, MO	December, 2010
Assisted Living	New Facility	75 Units	Columbia, SC	May, 2011
Assisted Living	Addition	46 Units	Franklin, TN	June, 2011

In the second quarter of 2011, we opened a 75-unit assisted living community in Columbia, South Carolina, as well as a 46-unit assisted living addition in Franklin, Tennessee. Also, in 2011, we expect to begin construction on a 90-bed skilled nursing facility in Tullahoma, Tennessee and a 92-bed skilled nursing facility in Hendersonville, Tennessee.

During 2011, we will apply for Certificates of Need for additional beds in our markets and also evaluate the feasibility of expansion into new markets by building private pay health care centers or by the purchase of existing health care centers. We will also evaluate the feasibility of construction of new assisted living facilities in select markets.

Accrued Risk Reserves

Our accrued professional liability reserves, workers’ compensation reserves and health insurance reserves totaled $96,322,000 at September 30, 2011, a 11.8% reduction since September 30, 2010, and are a primary area of management focus. The reduction in our accrued risk reserves within the past twelve months is due to the settlements of claims and the revision to estimates within the reserves. We have set aside restricted cash and cash equivalents and marketable securities to fund substantially all of our professional liability and workers’ compensation liabilities.

As to exposure for professional liability claims, we have developed performance certification criteria to measure and bring focus to the patient care issues most likely to produce professional liability exposure, including in–house acquired pressure ulcers, significant weight loss and numbers of falls. These programs for certification, which we regularly modify and improve, have produced measurable improvements in reducing these incidents. Our experience is that achieving goals in these patient care areas improves both patient and employee satisfaction.

Application of Critical Accounting Policies

There have been no significant changes during the nine month period ended September 30, 2011 to the items we disclosed as our critical accounting policies and estimates in our discussion and analysis of financial condition and results of operations in our December 31, 2010 Annual Report on Form 10-K filed with the SEC.

Government Program Financial Changes

Cost containment will continue to be a priority for Federal and State governments for health care services, including the types of services we provide. Government reimbursement programs such as Medicare and Medicaid prescribe, by law, the billing methods and amounts that health care providers may charge and be reimbursed to care for patients covered by these programs. Congress has passed a number of laws that have effected major changes in

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

the Medicare and Medicaid programs. The Balanced Budget Act of 1997 sought to achieve a balanced federal budget by, among other things, reducing federal spending on Medicare and Medicaid to various providers. The Balanced Budget Act of 1997 defined the Medicare Prospective Payment System ("PPS") and this System has subsequently been refined in 1999, 2000, 2005, 2006 and 2010.

Federal Health Care Reform

In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act ("PPACA") and the Health Care and Education Reconciliation Act of 2010 ("HCERA"), which represents significant changes to the current U.S. health care system (collectively the "Acts"). The Acts affect aging services providers, our partners (employees) and our patients and residents in a multitude of ways. We have evaluated the provisions of the Acts and do not expect material effects on our results of operations, liquidity and cash flows in 2011. We anticipate many of the provisions of the Acts may be subject to further clarification and modification through the rule-making process. It is uncertain at this time the effect the Acts and their modifications will have on our future results of operations or cash flows.

In December 2010, President Obama signed into law the Medicare and Medicaid Extenders Act (“MMEA”). This legislation affects numerous health care providers and makes several important technical corrections to the health reform laws enacted earlier in 2010. An important item provided for in the MMEA legislation is for an immediate and retroactive updated methodology (Resource Utilization Group – Version Four, “RUG-IV”) for determining Medicare payment rates to skilled nursing centers. The MMEA allowed skilled nursing center rates determined by RUG-IV to be applied as of October 1, 2010.

In August 2011 and pursuant to the Budget Control Act of 2011, Congress created a 12-member bipartisan committee called the Joint Select Committee on Deficit Reduction, or the Joint Committee. The Joint Committee has until November 23, 2011 to report legislation to Congress for achieving at least $1.2 trillion in budget savings over ten years. Congress will consider the legislation under fast track procedures and has until December 23, 2011 to pass or reject the legislation. Failure to enact the legislation by the deadline will trigger automatic reductions in discretionary and mandatory spending starting in 2013, including reductions of not more than 2% to payments to Medicare providers. Members of Congress and the Obama administration have made various cost cutting recommendations to the Joint Committee, such as reductions in Medicare payments to SNF’s. We are unable to predict the financial impact of the legislation to be proposed by the Joint Committee, if enacted, or of the automatic payment cuts beginning in 2013 if the legislation is not enacted. However, such impact may be adverse and material to our future results of operations and cash flows.

Medicare

Effective October 1, 2010, the federal RUG rates had a market basket increase of 2.3%. There was also a (0.6%) forecasting error adjustment, generating a net market basket increase of 1.7%. According to the CMS, the transition from RUG-III to RUG-IV would be on a budget neutral basis. CMS states RUG-IV was needed to recalibrate the case-mix system after changes in fiscal year 2006 caused payments to skilled nursing centers to exceed budget neutrality estimates. The effect of the RUG-IV rate changes on our revenues is dependent upon our census and the mix of our patients at the PPS pay rates. The PPS rates had a net market basket decrease of 1.1% in 2009.

For the first nine months of 2011, our average Medicare per diem rate increased 20.5% compared to the same period in 2010. The increase is due to both the October 1, 2010 RUG-IV rate changes and the increased acuity levels of the patients in our skilled nursing centers.

On July 29, 2011, CMS issued a final rule providing for, among other things, a net 11.1% reduction in PPS payments to skilled nursing facilities for CMS's fiscal year 2012 (which began October 1, 2011) as compared to PPS payments in CMS's fiscal year 2011 (which ended September 30, 2011). The 11.1% reduction is on a net basis, after the application of a 2.7% market basket increase less a 1.0% multi-factor productivity adjustment required by the Patient Protection and Affordable Care Act of 2010 ("PPACA"). The final CMS rule also adjusts the method by which group therapy is counted for reimbursement purposes, and changes the timing in which patients who are

receiving therapy must be reassessed for purposes of determining their RUG category. We anticipate that, assuming other factors remain constant, CMS's reduced reimbursement rates and other changes effective for its fiscal year 2012 will have a significant and adverse effect on our results of operations when compared to the periods in CMS's fiscal year 2011. We estimate the resulting decrease in revenue from the fiscal year 2012 Medicare rate changes will be approximately $24,000,000 annually, or $6,000,000 per quarter. The effect of the rate changes on our revenues is dependent upon our census and the mix of our patients at the recalibrated PPS pay rates. We are examining cost saving measures that are available to us to help mitigate the effects of a portion of the revenue decrease, but we are committed to maintaining the quality of care to our patients.

Effective October 1, 2010, hospice agencies received Medicare payments which represented a 1.8% increase. Effective October 1, 2011, hospice agencies will receive a 2.5% increase in their Medicare payments over fiscal year 2011. We estimate the effect of the revenue increase for NHC hospice programs to be approximately $300,000 annually, or $75,000 per quarter.

Effective January 2011, home health agencies received Medicare payments which represented a 5.2% decrease. We estimate the effect of the revenue decrease for NHC homecare programs to be approximately $3,400,000 annually, or $850,000 per quarter.

Medicaid

On April 18, 2011, effectively immediately, South Carolina implemented a three percent Medicaid rate reduction. We estimate the resulting decrease in revenue will be approximately $370,000 per quarter.

No rate increases or decreases were implemented for the fiscal years beginning July 1, 2011 for Medicaid programs in the states of Tennessee and Missouri. Tennessee, however, has announced that it will implement a 4.25% rate reduction beginning January 1, 2012. We estimate the resulting decrease in revenue in Tennessee will be approximately $650,000 per quarter.

For the first nine months of 2011, our average Medicaid per diem overall increased by 0.7% compared to the same period in 2010. We face challenges with respect to states’ Medicaid payments because many states currently do not cover the total costs incurred in providing care to those patients. States will continue to control Medicaid expenditures but also look for adequate funding sources, including provider assessments. Other provisions could increase state funding for home and community-based services, potentially having an impact on funding for nursing facilities. There is no assurance that the funding for our services will increase or decrease in the future.

Results of Operations

Three Months Ended September 30, 2011 Compared to Three Months Ended September 30, 2010

Results for the three month period ended September 30, 2011 include a 10.4% increase in net operating revenues and a 17.2% increase in income before taxes compared to the same period in 2010.

Net patient revenues increased $16,790,000 or 10.2% compared to the same period last year. Medicare and Managed Care per diem rates increased 21.7% and 7.8%, respectively, compared to the quarter a year ago. Medicaid per diem rates decreased 0.9% compared to the quarter a year ago. The newly constructed or acquired businesses (three skilled nursing facilities and one assisted living community) helped increase net patient revenues approximately $5,112,000.

The total census at owned and leased long-term health care centers for the quarter averaged 90.5% compared to an average of 92.1% for the same quarter a year ago.

Other revenues increased $1,723,000 or 13.0% in the three-month 2011 period to $14,930,000 from $13,207,000 in the 2010 three-month period. The increase in other revenues is primarily due to the increased

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

collections of management and accounting services fees of $1,588,000, as further detailed in Note 3 of our interim condensed consolidated financial statements. Rental income also increased $320,000 due to the renewed rental agreements of thirteen of our properties with third party operators.

Non-operating income decreased by $284,000 to $5,140,000 in the three-month 2011 period in comparison to $5,424,000 for the three-month 2010 period, as further detailed in Note 4 to our interim condensed consolidated financial statements.

Total costs and expenses for the 2011 third quarter compared to the 2010 third quarter increased $14,839,000 or 9.0% to $179,120,000 from $164,281,000. Salaries, wages and benefits, the largest operating costs of this service company, increased $8,339,000 or 8.5% to $106,870,000 from $98,531,000. Other operating expenses increased $5,511,000 or 11.2% to $54,807,000 for the 2011 period compared to $49,296,000 for the 2010 period. Facility rent expense increased $482,000 or 5.1% to $10,000,000. Depreciation and amortization increased 7.5% to $7,307,000.

The increase in salaries, wages and benefits is primarily due to the increased staffing from the opening or acquisition of three skilled nursing facilities and one assisted living community ($2,578,000). We also had increased costs in our existing skilled nursing facilities ($3,101,000), increased costs for therapist services ($1,614,000), and inflationary wage increases.

The increase in other operating expenses is primarily due to the opening or acquisition of the new operations ($2,224,000) and an increased provision in accrued risk reserves of $1,206,000 compared to the quarter a year ago.

Facility rent expense for the three months ended September 30, 2011 increased by approximately $482,000 compared to the quarter a year ago. The increase is due to the increased percentage rent accrued and paid to National Health Investors, Inc. (“NHI”). Percentage rent to NHI is equal to 4% of the increase in facility revenues over the 2007 revenues, the base year of the lease agreement.

Depreciation expense increased primarily due to the acquisition and construction of depreciable assets in the last year. The increase in depreciation for the three months ended September 30, 2011 was $507,000.

The income tax provision for the three months ended September 30, 2011 is $5,873,000 (an effective income tax rate of 25.4 %). The income tax provision and effective tax rate for the three months ended September 30, 2011 were unfavorably impacted by adjustments to unrecognized tax benefits resulting in an increase in the provision of $23,000 or 0.1% of income before taxes. The income tax provision and effective tax rate for 2011 were favorably impacted by statute of limitations expirations resulting in a benefit to the provision of $3,226,000 or 14.0% of income before taxes in 2011. The income tax provision for the three months ended September 30, 2010 was $4,611,000 (an effective tax rate of 23.4%). The income tax provision and effective tax rate for the three months ended September 30, 2010 were unfavorably impacted by adjustments to unrecognized tax benefits resulting in an increase in the provision of $651,000 or 3.3% of income before taxes. The income tax provision and effective tax rate for the three months ended September 30, 2010 were favorably impacted by statute of limitation expirations resulting in a benefit to the provision of $3,721,000 or 18.9% of income before taxes in 2010.

Nine Months Ended September 30, 2011 Compared to Nine Months Ended September 30, 2010

Results for the nine month period ended September 30, 2011 include a 9.8% increase in net operating revenues and a 35.0% increase in income before taxes compared to the same period in 2010.

Net patient revenues increased $50,378,000 or 10.4% compared to the same period last year. Medicare, Managed Care, and Medicaid per diem rates increased 20.5%, 8.6%, and 0.7%, respectively, compared to the nine months a year ago. The newly constructed or acquired businesses (three skilled nursing facilities and one assisted living community) helped increase net patient revenues approximately $14,525,000.

The total census at owned and leased long-term health care centers for the nine months averaged 90.7% compared to an average of 92.0% for the same period a year ago.

Other revenues increased $1,620,000 or 3.8% in the nine-month 2011 period to $44,264,000 from $42,644,000 in the 2010 nine-month period. The increase in other revenues is primarily due to the increased collection of management and accounting services fees of $1,177,000, as further detailed in Note 3 of our interim condensed consolidated financial statements. Rental income also increased due to the renewed rental agreements of thirteen of our properties with third party operators.

Non-operating income decreased by $102,000 to $14,856,000 in the nine-month 2011 period in comparison to $14,958,000 for the nine-month 2010 period, as further detailed in Note 4 of our interim condensed consolidated financial statements.

Total costs and expenses for the 2011 nine months compared to the 2010 period increased $32,260,000 or 6.6% to $519,930,000 from $487,670,000. Salaries, wages and benefits, the largest operating costs of this service company, increased $28,138,000 or 9.6% to $320,425,000 from $292,287,000. Other operating expenses increased $1,427,000 or 1.0% to $148,084,000 for the 2011 period compared to $146,657,000 for the 2010 period. Rent expense increased $1,304,000 or 4.6% to $29,744,000. Depreciation and amortization increased 7.3% to $21,344,000.

The increase in salaries, wages and benefits is primarily due to the increased staffing from the opening or acquisition of three skilled nursing facilities and one assisted living community ($7,510,000). We also had increased costs in our existing skilled nursing facilities ($9,207,000), increased costs for therapist services ($4,445,000), and inflationary wage increases.

The increase in other operating expenses is primarily due to the opening or acquisition of the new operations ($6,498,000). We also had increased costs in our existing skilled nursing facilities ($5,963,000), but the increases in expenses were offset due to the favorable results within our accrued risk reserves of approximately $8,486,000.

Rent expense for the nine months ended September 30, 2011 increased by approximately $1,304,000 compared to the nine month period a year ago. The increase is due to the increased percentage rent accrued and paid to National Health Investors, Inc. (“NHI”). Percentage rent to NHI is equal to 4% of the increase in facility revenues over the 2007 revenues, the base year of the lease agreement.

Depreciation expense increased primarily due to the acquisition and construction of depreciable assets in the last year. The increase in depreciation for the nine months ended September 30, 2011 was $1,454,000.

The income tax provision for the nine months ended September 30, 2011 is $26,175,000 (an effective income tax rate of 34.6 %). The income tax provision and effective tax rate for the nine months ended September 30, 2011 were favorably impacted by adjustments to unrecognized tax benefits resulting in a decrease in the provision of $45,000 or 0.1% of income before taxes. The income tax provision and effective tax rate for 2011 were favorably impacted by statute of limitations expirations resulting in a benefit to the provision of $3,226,000 or 4.3% of income before taxes in 2011. The income tax provision for the nine months ended September 30, 2010 was $18,745,000 (an effective tax rate of 33.4%). The income tax provision and effective tax rate for the nine months ended September 30, 2010 were unfavorably impacted by adjustments to unrecognized tax benefits resulting in an increase in the provision of $786,000 or 1.4% of income before taxes. The income tax provision and effective tax rate for the nine months ended 2010 were favorably impacted by statute of limitation expirations resulting in a benefit to the provision of $3,721,000 or 6.6% of income before taxes in 2010.

Liquidity, Capital Resources, and Financial Condition

Our primary sources of cash include revenues from the operations of our healthcare and senior living facilities, insurance services, management services and accounting services. Our primary uses of cash include

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

salaries, wages and other operating costs of our healthcare and senior living facilities, the cost of additions to and acquisitions of real property, facility rent expenses, and dividend distributions. These sources and uses of cash are reflected in our Interim Condensed Consolidated Statements of Cash Flows and are discussed in further detail below. The following is a summary of our sources and uses of cash flows (dollars in thousands):


		Nine Months Ended September 30				Nine Month Change
		2011		2010		$	%
Cash and cash equivalents at beginning of period	$	28,478	$	39,022	$	(10,544)	(27.0)%

Cash provided from operating activities		53,774		45,799		7,975	17.4%

Cash used in investing activities		(17,782)		(33,684)		15,902	47.2%

Cash used in financing activities		(11,312)		(22,269)		10,957	49.2%

Cash and cash equivalents at end of period	$	53,158	$	28,868	$	24,290	84.1%

Operating Activities

Net cash provided by operating activities for the nine months ended September 30, 2011 was $53,774,000 as compared to $45,799,000 in the same period last year. Cash provided by operating activities consisted of net income of $49,546,000, adjustments for non-cash items of $22,596,000, and $18,368,000 used for working capital. Cash used for working capital primarily consisted of an increase in restricted cash and cash equivalents of $8,027,000, a decrease in accounts receivable of $7,995,000, and a decrease in accrued risk reserves of $8,737,000.

The increase in restricted cash and cash equivalents is from NHC healthcare entities paying insurance premiums into NHC insurance companies, which restrict the cash payment. The decrease in accounts receivable is primarily from National paying balances related to interim payroll and benefit services outstanding at December 31, 2010. The decrease in accrued risk reserves is due from the favorable results for the 2011 nine month period.

Investing Activities

Cash used in investing activities totaled $17,782,000 and $33,684,000 for the nine months ended September 30, 2011 and 2010, respectively. Cash used for property and equipment additions was $17,881,000 for the nine months ended September 30, 2011 and $18,919,000 in the comparable period in 2010. For the 2010 nine-month period, cash in the amount of $14,342,000 was used in the May 1, 2010 acquisition of three homecare programs in South Carolina. Cash provided by net collections of notes receivable was $1,573,000 in 2011 compared to $1,026,000 in 2010. Purchases and sales of restricted marketable securities resulted in a net use of cash of $1,474,000 for the 2011 period compared to $1,449,000 for the 2010 period.

Costs included in property and equipment additions include $3,075,000 for the construction of the 75-unit assisted living community in Columbia, South Carolina and $2,536,000 for the 46-unit assisted living addition to our Franklin, Tennessee community. Both of the projects were completed in the second quarter of 2011.

Financing Activities

Net cash used in financing activities totaled $11,312,000 for the nine months ended September 30, 2011 compared to $22,269,000 in the same period in 2010. Cash used for dividend payments to common and preferred stockholders totaled $18,314,000 in the current year period. In the prior period, cash used for dividend payments to common and preferred stockholders totaled $17,487,000. In the current period, $7,152,000 of cash was provided by the issuance of common stock. In the prior period, cash of $5,944,000 was used to repurchase 182,900 shares of common stock.

Table of Contractual Cash Obligations

Our contractual cash obligations for periods subsequent to September 30, 2011 are as follows (in thousands):


		Total		1 year		1-3 Years		3-5 Years		After 5 Years
Long-term debt – principal	$	10,000	$	−	$	−	$	−	$	10,000
Long-term debt – interest		1,727		276		553		553		345
Operating leases		345,425		33,700		67,400		67,400		176,925
Total Contractual Cash Obligations	$	357,152	$	33,976	$	67,953	$	67,953	$	187,270

Other noncurrent liabilities for uncertain tax positions of $4,457,000, attributable to permanent differences, at September 30, 2011 has not been included in the above table because of the inability to estimate the period in which the tax payment is expected to occur. See Note 12 of the Interim Condensed Consolidated Financial Statements for a discussion on income taxes.

We started paying quarterly dividends on our common shares outstanding in 2004 and our preferred shares outstanding in 2007. We anticipate the continuation of both the common and preferred dividend payments as approved quarterly by the Board of Directors.

Short-term liquidity

We expect to meet our short-term liquidity requirements primarily from our cash flows from operating activities. In addition to cash flows from operations, our current cash on hand of $53,158,000 at September 30, 2011, marketable securities of $80,089,000 at September 30, 2011 and as needed, our borrowing capacity, are expected to be adequate to meet our contractual obligations and to finance our operating requirements and our growth and development plans in the next twelve months. We currently do not have any funds drawn against our revolving credit agreement and the amount of $75,000,000 is available to be drawn for general corporate purposes, including working capital and acquisitions.

Long-term liquidity

Our $75,000,000 revolving credit agreement matures on October 25, 2012. We currently anticipate renewing the credit agreement at that time and while we have had no indication from the lender that there is any question about renewal, there has been no commitment at this time. We entered into this loan originally on October 30, 2007, and have renewed the loan four times with one year maturities. At the inception and at each renewal, the lender offered longer maturities, but the Company chose a one-year maturity because of the terms. If we are not able to refinance our debt as it matures, we will be required to use our cash and marketable securities to meet our debt and contractual obligations and will be limited in our ability to fund future growth opportunities.

Our ability to refinance the credit agreement, to meet our long-term contractual obligations and to finance our operating requirements, and growth and development plans will depend upon our future performance, which will be affected by business, economic, financial and other factors, including potential changes in state and federal government payment rates for healthcare, customer demand, success of our marketing efforts, pressures from competitors, and the state of the economy, including the state of financial and credit markets.

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

Commitment and Contingencies

Governmental Regulations

Laws and regulations governing the Medicare, Medicaid and other federal healthcare programs are complex and subject to interpretation. Management believes that it is in compliance with all applicable laws and regulations in all material respects. However, compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusions from the Medicare, Medicaid and other federal healthcare programs. We are not aware of any material regulatory proceeding or investigation underway or threatened involving allegations of potential wrongdoing.

Acquisitions

We have acquired and will continue to acquire businesses with prior operating histories. Acquired companies may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, anti-kickback and physician self-referral laws. Although we institute policies designed to conform practices to our standards following completion of acquisitions and attempts to structure our acquisitions as asset acquisitions in which we do not assume liability for seller wrongful actions, there can be no assurance that we will not become liable for past activities that may later be alleged to be improper by private plaintiffs or government agencies. Although we obtain general indemnifications from sellers covering such matters, there can be no assurance that any specific matter will be covered by such indemnifications, or if covered, that such indemnifications will be adequate to cover potential losses and fines.

Inflation

We have historically derived a substantial portion of our revenue from the Medicare and Medicaid programs, along with similar reimbursement programs. Payments under these programs generally provide for reimbursement levels that are adjusted for inflation annually based upon the state’s fiscal year for the Medicaid programs and in each October for the Medicare program. The adjustments may not continue in the future, and even if received, such adjustments may not reflect the actual increase in our costs for providing healthcare services.

New Accounting Pronouncements

See Note 2 to the Interim Condensed Consolidated Financial Statements for the impact of new accounting standards.

Forward–Looking Statements

References throughout this document to the Company include National HealthCare Corporation and its wholly–owned subsidiaries. In accordance with the Securities and Exchange Commissions “Plain English” guidelines, this Quarterly Report on Form 10–Q has been written in the first person. In this document, the words “we”, “our”, “ours” and “us” refer only to National HealthCare Corporation and its wholly–owned subsidiaries and not any other person.

This Quarterly Report on Form 10–Q and other information we provide from time to time, contains certain “forward–looking” statements as that term is defined by the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations or cash flows, continued performance improvements, ability to service and refinance our debt obligations, ability to finance growth opportunities, ability to control our patient care liability costs, ability to respond to changes in government

regulations, ability to execute our three–year strategic plan, and similar statements including, without limitations, those containing words such as “believes”, “anticipates”, “expects”, “intends”, “estimates”, “plans”, and other similar expressions are forward–looking statements.

Forward–looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward–looking statements as a result of, but not limited to, the following factors:

national and local economic conditions, including their effect on the availability and cost of labor, utilities and materials;

the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations;

changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries;

liabilities and other claims asserted against us, including patient care liabilities, as well as the resolution of current litigation (see Note 12: Guarantees and Contingencies);

the ability of third parties for whom we have guaranteed debt, if any, to refinance certain short term debt obligations;

the ability to attract and retain qualified personnel;

the availability and terms of capital to fund acquisitions and capital improvements;

the ability to refinance existing debt on favorable terms;

the competitive environment in which we operate;

the ability to maintain and increase census levels; and

demographic changes.

See the notes to the quarterly financial statements, and “Item 1. Business” as is found in our 2010 Annual Report on Form 10–K for a discussion of various governmental regulations and other operating factors relating to the healthcare industry and the risk factors inherent in them. This may be found on our web side at www.nhccare.com. You should carefully consider these risks before making any investment in the Company. These risks and uncertainties are not the only ones facing us. There may be additional risks that we do not presently know of or that we currently deem immaterial. If any of the risks actually occur, our business, financial condition or results of operations could be materially adversely affected. In that case, the trading price of our shares of stock could decline, and you may lose all or part of your investment. Given these risks and uncertainties, we can give no assurances that these forward–looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk.

Market risk represents the potential economic loss arising from adverse changes in the fair value of financial instruments. Currently, our exposure to market risk relates primarily to our fixed-income and equity portfolios. These investment portfolios are exposed primarily to, but not limited to, interest rate risk, credit risk, equity price risk, and concentration risk. We also have exposure to market risk that includes our cash and cash equivalents, notes receivable, revolving credit facility, and long-term debt. The Company's senior management has established comprehensive risk management policies and procedures to manage these market risks.

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

Interest Rate Risk

The fair values of our fixed-income investments fluctuate in response to changes in market interest rates. Increases and decreases in prevailing interest rates generally translate into decreases and increases, respectively, in the fair values of those instruments. Additionally, the fair values of interest rate sensitive instruments may be affected by the creditworthiness of the issuer, prepayment options, the liquidity of the instrument and other general market conditions. At September 30, 2011, we have available for sale debt securities in the amount of $84.7 million. The fixed maturity portfolio is comprised of investments with primarily short-term and intermediate-term maturities. The portfolio composition allows flexibility in reacting to fluctuations of interest rates. The fixed maturity portfolio allows our insurance company subsidiaries to achieve an adequate risk-adjusted return while maintaining sufficient liquidity to meet obligations.

As of September 30, 2011, both our long-term debt and revolving credit facility bear interest at variable interest rates. Currently, we have long-term debt outstanding of $10.0 million and the revolving credit facility is zero. However, we do intend to borrow funds on our credit facility in the future. Based on a hypothetical credit facility borrowing of $75.0 million and our outstanding long-term debt, a 1% change in interest rates would change our annual interest cost by approximately $850,000.

Approximately $4.7 million of our notes receivable bear interest at variable rates (generally at the prime rate plus 2%). Because the interest rates of these instruments are variable, a hypothetical 1% change in interest rates would result in a related increase or decrease in interest income of approximately $47,000.

Our cash and cash equivalents consist of highly liquid investments with a maturity of less than three months when purchased. As a result of the short-term nature of our cash instruments, a hypothetical 1% change in interest rates would have minimal impact on our future earnings and cash flows related to these instruments.

We do not currently use any derivative instruments to hedge our interest rate exposure. We have not used derivative instruments for trading purposes and the use of such instruments in the future would be subject to approvals by the Investment Committee of the Board.

Credit Risk

Credit risk is managed by diversifying the fixed maturity portfolio to avoid concentrations in any single industry group or issuer and by limiting investments in securities with lower credit ratings.

Equity Price and Concentration Risk

Our available for sale equity securities are recorded at their fair market value based on quoted market prices. Thus, there is exposure to equity price risk, which is the potential change in fair value due to a change in quoted market prices. At September 30, 2011, the fair value of our equity marketable securities is approximately $80.1 million. Of the $80.1 million equity securities portfolio, our investment in National Health Investors, Inc. (“NHI”) comprises approximately $68.7 million, or 85.8%, of the total fair value. We manage our exposure to NHI by closely monitoring the financial condition, performance, and outlook of the company. Hypothetically, a 10% change in quoted market prices would result in a related increase or decrease in the fair value of our equity investments of approximately $8.0 million. At September 30, 2011, our equity securities had unrealized gains of $52.9 million and unrealized losses of $321,000. Of the $52.9 million of unrealized gains, $44.0 million is related to our investment in NHI.

Item 4. Controls and Procedures.

As of September 30, 2011, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (“CEO”) and Principal Accounting Officer (“PAO”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on that evaluation, the Company’s management, including the CEO and PAO, concluded that the Company’s

disclosure controls and procedures were effective as of September 30, 2011. There have been no changes in the Company’s internal control over financial reporting during the quarter ended September 30, 2011 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

For a discussion of prior, current and pending litigation of material significance to NHC, please see Note 13 of this Form 10–Q.

Item 1A. Risk Factors.

During the nine months ended September 30, 2011, there were no material changes to the risk factors that were disclosed in Item 1A of National HealthCare Corporation’s Annual Report on Form 10–K for the year ended December 31, 2010.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. Not applicable

Item 3. Defaults Upon Senior Securities. None

Item 5. Other Information. None

Item 6. Exhibits.

(a)

List of exhibits


Exhibit No.	Description

31.1	Rule 13a–14(a)/15d–14(a) Certification of Chief Executive Officer

31.2	Rule 13a–14(a)/15d–14(a) Certification of Principal Financial Officer

32	Certification pursuant to 18 U.S.C. Section 906 by Chief Executive
	Officer and Principal Financial Officer

101.INS	XBRL Instance Document

101.SCH	XBRL Taxonomy Extension Schema Document

101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF	XBRL Taxonomy Extension Definition Linkbase Document

101.LAB	XBRL Taxonomy Extension Label Linkbase Document

101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

NATIONAL HEALTHCARE CORPORATION

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2011

(unaudited)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	NATIONAL HEALTHCARE CORPORATION
	(Registrant)

Date: November 3, 2011	/s/ Robert G. Adams
	Robert G. Adams
	Chief Executive Officer


Date: November 3, 2011	/s/ Donald K. Daniel
	Donald K. Daniel
	Senior Vice President and Controller
	(Principal Financial Officer)

NATIONAL HEALTHCARE CORP - FORM 10-Q - November 3, 2011

Attached files

NATIONAL HEALTHCARE CORP Reports